LAST PRICE - AT THE CLOSE
EMRAF is DOWN -10% since the begininning of the year
EMRAF is DOWN -1% BELOW 20 day SMA
EMRAF is DOWN -7% BELOW 200 day SMA
PROFITABLE: YES
EPS: $0.7636
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 12.7256
INCOME TO DEBT RATIO: 0.05
 |
THE STOCK IS 35.6% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS DOWN -10% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS DOWN -21% OVER THE PAST 12 MONTHS |
 |
EMRAF IS DOWN -2% OVER THE PAST 1 MONTH |
 |
1% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | Gap reversal, Gap=-0... | 05/01 |
 | New 60 minute high. | 05/01 |
 | New 60 minute low. | 05/01 |
 | Opening range breako... | 05/01 |
 | 60 minute MACD cross... | 05/01 |
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0.02 over the last hour |
 |
EMRAF is up 1.4% over the last 5 days |
 |
EMRAF is 0.5 above its 8 day SMA |
| $33.56 |   DAY |
$33.89 |
| $33.44 | PREVIOUS DAY |
$33.86 |
| $33.44 |  WEEK |
$35.78 |
| $32.00 | MONTH |
$35.78 |
| $31.85 | YEAR |
$44.13 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
